Postdoctoral Positions in the Glycosciences with emphasis on Immunology, Infectious disease, Dermatology, and Atherosclerosis
The National Heart, Lung and Blood Institute (NHLBI) has awarded the University of California, San Diego, a program project grant as part of a national network of Programs of Excellence in Glycosciences (PEG). The goal of the PEG is to translate emerging discoveries in glycosciences into new diagnostics and clinical applications, to build research capacity and resources and a cadre of scientifically bilingual investigators fluent in glycan chemistry and biology that will sustain and advance the application of glycosciences to heart, lung, and blood research.
Towards this goal, the PEG located at University of California, San Diego is currently seeking candidates holding an MD, MD/PhD, or PhD degree who wish to obtain skill in the glycosciences broadly related to inflammation, with particular emphasis in immunology, infectious disease, dermatology, and atherosclerosis. Participating faculty include Ajit Varki, MD (Siglec Modulation of Innate Immunity and Inflammation), Victor Nizet, MD (Microbial Glycan Mimicry and Glycosidases in Inflammatory Responses), Jeffrey Esko, PhD (Genetic Analysis of Glycosaminoglycans in Inflammatory Responses), and Richard Gallo, MD, PhD (Hyaluronan Catabolism in Inflammatory Responses).
Successful candidates will have the opportunity to take didactic courses related to the Glycosciences, obtain hands-on experience with analytical techniques, and experience both clinical and biotechnological application of glycosciences. Interested individuals should apply directly to the faculty member in whose laboratory they wish to work. The University of California, San Diego is an Equal Opportunity/Affirmative Action Employer with a strong institutional commitment to the achievement of diversity among its faculty and staff.